LDLR and Disorder of lipid metabolism: To our knowledge, this study is the first to provide evidence that Ang-(1–7)-mediated regulation of chronic inflammation could ameliorate renal injury induced by lipid metabolism disorders through the LDLr-SREBP2-SCAP pathway.